Developing next-generation immunotherapies that precisely leverage the immune system of each patient.
About Anocca
An innovative therapeutic biotechnology company with unique expertise, technologies and capabilities.
Technology Platform
A technology platform that deploys highly engineered human cellular, genetic and molecular tools to rapidly and accurately interrogate the adaptive immune system so as to develop and manufacture T-cell therapies and reagents.
Pipeline
An advancing preclinical T-Cell Receptor (TCR) asset pipeline with multiple novel therapies and reagents for the treatment of cancer and infectious disease.